Vitamin C Intake and Anti-Tuberculosis Drugs-Induced Hepatitis in Pulmonary Tuberculosis Patients
Downloads
Introduction: Drug-induced hepatitis (DIH) is one of the serious side effects of anti-tuberculosis drugs (ATD) that can reduce patient compliance with tuberculosis (TB) treatment, increase the risk of treatment failure, or develop drug resistance. Vitamin C is a potential antioxidant known to have a protective effect against DIH. This study examined the relationship between vitamin C intake and the incidence of ATD-induced hepatitis (ATDIH) in pulmonary TB patients at Persahabatan National Respiratory Referral Hospital, Jakarta.
Methods: This was a cross-sectional study of 108 patients with drug-sensitive pulmonary TB. Data was collected using a sociodemographic questionnaire, anthropometric measurements, semi-quantitative food frequency questionnaire (SQ FFQ), and data on the subject's liver function laboratory results in the last 1 month. Fisher exact test was utilized to analyze the association between adequacy of vitamin C intake and DIH.
Results: The proportion of DIH in pulmonary TB patients in this study was 6.5%. Most subjects were males (54.6%) with a median age of 41. The median vitamin C intake was 66.65 mg/day, with 63.0% of patients having an intake below the recommendation. Fisher's exact test showed that vitamin C intake was not statistically significantly associated with the incidence of ATDIH (OR 3.77 95% CI 0.44-32.55, p-value 0.256). No factors also influenced the incidence of ATDIH in this study.
Conclusion: No association was found between vitamin C intake and other factors related to the incidence of ATDIH. This is the first study in Indonesia to link vitamin C and E intake with the incidence of DIH in drug-sensitive pulmonary TB patients, providing information for future studies.
World Health Organization (WHO). Global Tuberculosis Report 2023. Geneva, https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2023 (2023).
Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. Jakarta: Kementerian Kesehatan Republik Indonesia, 2020. [Website]
Wang J, Xiong K, Xu L, et al. Dietary Intake of Vegetables and Cooking Oil was Associated with Drug-Induced Liver Injury During Tuberculosis Treatment: A Preliminary Cohort Study. Front Nutr 2021; 8: 652311. [PubMed]
Soedarsono S, Riadi ARW. Tuberculosis Drug-Induced Liver Injury . J Respirasi 2020; 6: 49–54. [Journal]
Villanueva-Paz M, Morán L, López-Alcántara N, et al. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel, Switzerland); 10. Epub ahead of print March 2021. [PubMed]
Ramappa V, Aithal GP. Hepatotoxicity Related to Anti-Tuberculosis Drugs: Mechanisms and Management. J Clin Exp Hepatol 2013; 3: 37–49. [PubMed]
Singh A, Prasad R, Balasubramanian V, et al. Prevalence of Adverse Drug Reaction with First-Line Drugs among Patients Treated for Pulmonary Tuberculosis. Clin Epidemiol Glob Heal 2015; 3: S80–S90. [ScienceDirect]
Patel S, Chaturvedi A, Dubey N, et al. Ascorbic Acid Ameliorates Isoniazid-Rifampicin-Induced Hepatocellular Damage in Rats. iLIVER 2022; 1: 72–77. [ScienceDirect]
Alli J, Kehinde A, Kosoko A, et al. Oxidative Stress and Reduced Vitamins C and E Levels are Associated with Multi-Drug Resistant Tuberculosis. J Tuberc Res 2014; 2: 52–58. [Journal]
Alaina D. The Relationship of Energy Intake, Protein, Vitamin B6, Vitamin C with the Nutritional Status of Lung Tuberculosis Patients in the Kemuning Room, Dr. M. Yunus Bengkulu in 2020. SANITAS J Teknol dan Seni Kesehat 2021; 12: 149–158. [Journal]
Vahdati-Mashhadian N, Jafari MR, Sharghi N, et al. Protective Effects of Vitamin C and NAC on the Toxicity of Rifampin on Hepg2 Cells. Iran J Pharm Res IJPR 2013; 12: 141–146. [PubMed]
Alorabi M, Mohammed DS, Mostafa-Hedeab G, et al. Combination Treatment of Omega-3 Fatty Acids and Vitamin C Exhibited Promising Therapeutic Effect against Oxidative Impairment of the Liver in Methotrexate-Intoxicated Mice. Biomed Res Int 2022; 2022: 4122166. [PubMed]
Adikwu E, Deo O. Hepatoprotective Effect of Vitamin C (Ascorbic Acid). Pharmacol Pharm 2013; 2013: 84–92. [Journal]
Adikwu E, Nelson B. Hepatoprotective Effect of Vitamin E. Am J Pharmacol Toxicol 2013; 7: 154–163. [Journal]
Ergul Y, Erkan T, Uzun H, et al. Effect of Vitamin C on Oxidative Liver Injury due to Isoniazid in Rats. Pediatr Int 2010; 52: 69–74. [PubMed]
Niu H, Sanabria-Cabrera J, Alvarez-Alvarez I, et al. Prevention and Management of Idiosyncratic Drug-Induced Liver Injury: Systematic Review and Meta-Analysis of Randomised Clinical Trials. Pharmacol Res 2021; 164: 105404. [PubMed]
Kementerian Kesehatan Republik Indonesia. Peraturan Menteri Kesehatan Republik Indonesia Nomor 28 Tahun 2019 tentang Angka Kecukupan Gizi yang Dianjurkan untuk Masyarakat Indonesia. 28, Indonesia, http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No__28_Th_2019_ttg_Angka_Kecukupan_Gizi_Yang_Dianjurkan_Untuk_Masyarakat_Indonesia.pdf (2019).
Xiong K, Wang J, Zhang J, et al. Association of Dietary Micronutrient Intake with Pulmonary Tuberculosis Treatment Failure Rate: ACohort Study. Nutrients; 12. Epub ahead of print August 2020. [PubMed]
Fitri ML, Nurwidya F, Manikam NRM, et al. Fat and Vitamin E Intake Affect Multidrug-Resistant Tuberculosis Patients’ Quality of Life: A Cross-Sectional Study. J Pak Med Assoc 2021; 71(Suppl 2): S53–S57. [PubMed]
Ren Z, Zhao F, Chen H, et al. Nutritional Intakes and Associated Factors among Tuberculosis Patients: A Cross-Sectional Study in China. BMC Infect Dis 2019; 19: 907. [PubMed]
Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients; 9. Epub ahead of print November 2017. [PubMed]
Carr A, Rowe S. Factors Affecting Vitamin C Status and Prevalence of Deficiency: A Global Health Perspective. Nutrients 2020; 12: 1963. [PubMed]
Badan Kebijakan Pembangunan Kesehatan. SKI 2023 dalam Angka. BKPK, https://www.badankebijakan.kemkes.go.id/ski-2023-dalam-angka/ (2023, accessed 6 May 2024).
Rifai A, Herlianto B, Mustika S, et al. Insiden dan Gambaran Klinis Hepatitis Akibat Obat Anti Tuberkulosis di Rumah Sakit Umum Daerah Dr. Saiful Anwar Malang. J Kedokt Brawijaya 2015; 28: 238–241. [Journal]
Pranata JR, Mariadi IK, Somayana G. Prevalensi dan Gambaran Umum Drug-Induced Liver Injury Akibat Obat Anti Tuberkulosis pada Pasien Tuberkulosis RSUP Sanglah Denpasar Periode Agustus 2016 – Juli 2017. E-Jurnal Med Udayana; 8, https://ojs.unud.ac.id/index.php/eum/article/view/53031 (2019).
Nur M, Iskandar H, Daud N, et al. Factors that Influence the Incidence of Drug Induced Liver Injury in Pulmonary Tuberculosis Patient. Int J Med Rev Case Reports 2019; 3: 1. [Journal]
Dasuki AA, Muti AF, Yusmaini H. Faktor Resiko Kejadian Peningkatan Kadar Transminase pada Penggunaan Obat Antituberkulosis Pasien Tuberkulosis Paru di RST Wijayakusuma Purwokerto. JFIOnline 2020; 12: 134–144. [Journal]
Jiang F, Yan H, Liang L, et al. Incidence and Risk Factors of Anti-Tuberculosis Drug Induced Liver Injury (DILI): Large Cohort Study Involving 4652 Chinese Adult Tuberculosis Patients. Liver Int 2021; 41: 1565–1575. [PubMed]
Molla Y, Wubetu M, Dessie B. Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia. Hepat Med 2021; 13: 1–8. [PubMed]
Gaude GS, Chaudhury A, Hattiholi J. Drug-Induced Hepatitis and the Risk Factors for Liver Injury in Pulmonary Tuberculosis Patients. J Fam Med Prim Care 2015; 4: 238–243. [PubMed]
Ali N, Gupta N, Saravu K. Malnutrition as an Important Risk Factor for Drug-Induced Liver Injury in Patients on Anti-Tubercular Therapy: An Experience from a Tertiary Care Center in South India. Drug Discov Ther 2020; 14: 135–138. [PubMed]
Gropper SS, Smith JL, Carr TP. Advanced Nutrition and Human Metabolism. Cengage Learning, https://books.google.co.id/books?id=vggVEAAAQBAJ (2021).
Pingili RB, Challa SR, Pawar AK, et al. A Systematic Review on Hepatoprotective Activity of Quercetin against Various Drugs and Toxic Agents: Evidence from Preclinical Studies. Phytother Res 2020; 34: 5–32. [PubMed]
Madrigal-Santillán E, Madrigal-Bujaidar E, Álvarez-González I, et al. Review of Natural Products with Hepatoprotective Effects. World J Gastroenterol 2014; 20: 14787–14804. [PubMed]
Bishayee A, Darvesh AS, Politis T, et al. Resveratrol and Liver Disease: From Bench to Bedside and Community. Liver Int 2010; 30: 1103–1114. [PubMed]
Mahayanti NKS, Sudarsana IPA. Laporan Kasus: Drug-Induced Liver Injury pada Pasien Tuberkulosis Relaps. Intisari Sains Medis 2022; 13: 792–795. [Journal]
Rahmani AH, Alsahli MA, Aly SM, et al. Role of Curcumin in Disease Prevention and Treatment. Adv Biomed Res 2018; 7: 38. [PubMed]
Farzaei MH, Zobeiri M, Parvizi F, et al. Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective. Nutrients; 10. Epub ahead of print July 2018. [PubMed]
Abera W, Cheneke W, Abebe G. Incidence of Antituberculosis-Drug-Induced Hepatotoxicity and Associated Risk Factors among Tuberculosis Patients in Dawro Zone, South Ethiopia: A Cohort Study. Int J Mycobacteriology 2016; 5: 14–20. [PubMed]
Soedarsono S, Mandayani S, Prayuni K, et al. The Risk Factors for Drug Induced Hepatitis in Pulmonary Tuberculosis Patients in Dr. Soetomo Hospital. Indones J Trop Infect Dis 2018; 7: 73–79. [Journal]
Tostmann A, Boeree MJ, Aarnoutse RE, et al. Antituberculosis Drug-Induced Hepatotoxicity: Concise Up-to-Date Review. J Gastroenterol Hepatol 2008; 23: 192–202. [PubMed]
Sukumaran D, Usharani P, Paramjyothi GK, et al. A Study to Evaluate the Hepatoprotective Effect of N- Acetylcysteine on Anti Tuberculosis Drug Induced Hepatotoxicity and Quality of Life. Indian J Tuberc 2023; 70: 303–310. [PubMed]
Yani MS, Singh G. Efek Hepatoprotektif N-Asetilsistein dalam Mencegah Drug-Induced Liver Injury Akibat Obat Antituberkulosis: Laporan Kasus Berbasis Bukti. Indones J CHEST Crit Emerg Med 2015; 2: 86–90. [Journal]
Aithal GP, Watkins PB, Andrade RJ, et al. Case Definition and Phenotype Standardization in Drug-Induced Liver Injury. Clin Pharmacol Ther 2011; 89: 806–815. [PubMed]
Yew WW, Chang KC, Chan DP. Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity. Antimicrob Agents Chemother; 62. Epub ahead of print August 2018. [PubMed]
Nehra R, Vishwakarma P, Nehra M, et al. Effect of α-Tocopherol on Antitubercular Drugs Induced Hepatotoxicity. Int J Res Med Sci 2016; 4: 1158–1162. [Journal]
Fahmida U, Dillon DHS, Handbook Nutritional Assessment. 2nd ed. SEAMEO-TROPMED RCCN, University of Indonesia, 2011.
Copyright (c) 2024 Hadiati Rabbani, Fariz Nurwidya, Diyah Eka Andayani, Heidy Agustin, Shaogi Syam
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.
JR (